NKGen Biotech (NKGN) Stock Price, Quote, News & History

Q: What sector and industry does NKGen Biotech (NKGN) operate in?

NKGen Biotech is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

NKGen Biotech (NKGN) Stock Price, Quote, News & History

NKGNOTCEM

Logo brought to you by Benzinga Data

Trade with Public

$0.1913

At close: Mar 14, 5:00 PM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

351.00 / 6.76K

Day Range

- - -

52 Wk Range

0.00 - 0.91

Market Cap

$7.84M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

46.34

Recent NKGen Biotech Inc News

Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Dow Falls Over 100 Points; Netflix Posts Upbeat Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-19.65M

Investing Cash Flow (TTM)

-100.00K

Financing Cash Flow (TTM)

19.49M

Free Cash Flow (TTM)

-19.75M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-255.00K

Valuation Metrics

Enterprise Value

$46.02M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-2216.67%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.39

Company Debt

Total Debt

$37.83M

LT Debt

$11.08M

LT Debt Issuance (TTM)

$17.78M

LT Debt Repayment (TTM)

Total Cash

$6.00K

Debt to Equity

Issuance of Debt (TTM)

$15.77M

Repayment of Debt (TTM)

-$4.01M

Key Statistics

Open

Volume / Avg.

351.00 / 6.76K

Day Range

- - -

52 Wk Range

0.00 - 0.91

Market Cap

$7.84M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

46.34

About

Sector

Health Care

Industry

Biotechnology

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NKGen Biotech (NKGN) stock?

You can purchase shares of NKGen Biotech (OTCEM:NKGN) through any online brokerage.

View our list of the best stock brokerages

Who are NKGen Biotech (NKGN) competitors?

There are no as such competitors for NKGen Biotech.

What is the forecast, or price target, for NKGen Biotech (NKGN) stock?

There is no analysis for NKGen Biotech to provide a consensus price target.

What is the current price for NKGen Biotech (NKGN)?

The stock price for NKGen Biotech (OTCEM: NKGN) is $0.06 last updated February 4, 2026 at 9:33 AM EST.

Does NKGen Biotech (NKGN) pay a dividend?

There are no upcoming dividends for NKGen Biotech.

When is NKGen Biotech (OTCEM:NKGN) reporting earnings?

NKGen Biotech does not have any upcoming earnings scheduled.

Is NKGen Biotech (NKGN) going to split?

There is no upcoming split for NKGen Biotech.

What sector and industry does NKGen Biotech (NKGN) operate in?

NKGen Biotech is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Edge Rankings